Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762275019 | Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3762276018 | Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Loteprednol etabonate + tobramycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Tobramycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Loteprednol etabonate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has manufactured dose form | Ocular dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Loteprednol etabonate ophthalmic preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Product containing tobramycin in ophthalmic dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has manufactured dose form | Conventional release eye suspension | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Product containing loteprednol and tobramycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Product containing loteprednol in ocular dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Product containing only loteprednol and tobramycin in ocular dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has precise active ingredient | Loteprednol etabonate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has precise active ingredient | Tobramycin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has basis of strength substance | Tobramycin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator value | 5 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator value | 3 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has basis of strength substance | Loteprednol etabonate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR